To read this content please select one of the options below:

Corporate strategy R&D and technology transfer in the European pharmaceutical industry: research findings

Chris C.B. Simango (Chris C.B. Simango is Senior Lecturer in Corporate Strategy at De Montfort University, Milton Keynes, UK.)

European Business Review

ISSN: 0955-534X

Article publication date: 1 February 2000

2579

Abstract

Discusses the extent to which American, European and Japanese pharmaceutical multinational enterprises (MNE) with subsidiaries in the Republic of Ireland have localised specific forms of R&D and contributed to technology transfer. Reports on a survey in which chief executive officers of Irish‐based MNE subsidiaries responded to mailed questionnaires. The reasons for corporate management to choose such operational strategic thrusts at business level have been highlighted with a view to focus on the degree to which Ireland is developing its pharmaceutical industrial base, as a result of attracting export‐led global pharmaceutical multinationals.

Keywords

Citation

Simango, C.C.B. (2000), "Corporate strategy R&D and technology transfer in the European pharmaceutical industry: research findings", European Business Review, Vol. 12 No. 1, pp. 28-33. https://doi.org/10.1108/09555340010307530

Publisher

:

MCB UP Ltd

Copyright © 2000, MCB UP Limited

Related articles